Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Miami Herald - Thursday, November 29, 2001
A four-year study of 1,028 HIV-infected children and teenagers found that combining protease inhibitors with standard AIDS drugs cut the risk of death by two-thirds, to less than 1 percent annually. The children "started growing, they started gaining weight, they started enjoying life," according to the study leader, Dr. James M. Oleske, in last week's New England Journal of Medicine.
Until recently, doctors were not sure if protease inhibitors would benefit children.
011129
MH011106
Copyright © 2001 - Miami Herald. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Miami Herald, Permissions, One Herald Plaza, Miami, FL 33132-1693 TEL: (305) 376-3719. http://www.herald.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .